Form D · Biotechnology

RHF IV Holding Company, LLC

Park City, UT · CIK 0002008220

Offering snapshot reported Jan 17, 2024 · SEC filing

Reported sold
$34.9M
Offering amount: $35M
Investors reported
125
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Mar 9, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 17, 2024Initial$34,940,000No comparison125SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$226K
Finders' fees
$0
Form D file number
021-502680

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Silver Leaf Partners LLC126694

Source: Form D, filed Jan 17, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

RHF IV HOLDING COMPANY, LLC

Investment adviser: SEVENTWO LLC

Gross asset value
$34.9M
Beneficial owners
125
ADV minimum commitment
$100K

Reported in Form ADV on Jun 12, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator RADEEZA SERVICES LLC CENTENNIAL, Colorado, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor CHERRY BEKAERT DENVER, Colorado, United States
Custodian SILICON VALLEY BANK DENVER, Colorado, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

CHERRY BEKAERT
PCAOB 677

Filing source

Form ADV 2110227 · Jun 12, 2026 · Schedule D 7.B.(1), fund 805-6205168114

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Marc S. Bathgate Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
8 Knob Hill
Park City, UT, 84098